| Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin … O Vaccaro, M Masulli, A Nicolucci, E Bonora, S Del Prato, AP Maggioni, ... The lancet Diabetes & endocrinology 5 (11), 887-897, 2017 | 277 | 2017 |
| SARS-CoV-2 receptor angiotensin I-converting enzyme type 2 (ACE2) is expressed in human pancreatic β-cells and in the human pancreas microvasculature D Fignani, G Licata, N Brusco, L Nigi, GE Grieco, L Marselli, L Overbergh, ... Frontiers in endocrinology 11, 596898, 2020 | 204 | 2020 |
| Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors S Culina, AI Lalanne, G Afonso, K Cerosaletti, S Pinto, G Sebastiani, ... Science immunology 3 (20), eaao4013, 2018 | 194 | 2018 |
| Conventional and neo-antigenic peptides presented by β cells are targeted by circulating naïve CD8+ T cells in type 1 diabetic and healthy donors S Gonzalez-Duque, ME Azoury, ML Colli, G Afonso, JV Turatsinze, L Nigi, ... Cell metabolism 28 (6), 946-960. e6, 2018 | 187 | 2018 |
| Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging? G Sebastiani, L Nigi, GE Grieco, F Mancarella, G Ventriglia, F Dotta Journal of endocrinological investigation 40, 591-610, 2017 | 105 | 2017 |
| MicroRNAs as regulators of insulin signaling: research updates and potential therapeutic perspectives in type 2 diabetes L Nigi, GE Grieco, G Ventriglia, N Brusco, F Mancarella, C Formichi, ... International journal of molecular sciences 19 (12), 3705, 2018 | 100 | 2018 |
| Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes F Vecchio, NL Buono, A Stabilini, L Nigi, MJ Dufort, S Geyer, PM Rancoita, ... JCI insight 3 (18), 2018 | 94 | 2018 |
| Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells E Ifie, MA Russell, S Dhayal, P Leete, G Sebastiani, L Nigi, F Dotta, ... Diabetologia 61, 2344-2355, 2018 | 73 | 2018 |
| Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells A Solini, G Sebastiani, L Nigi, E Santini, C Rossi, F Dotta Diabetes & metabolism 43 (6), 512-520, 2017 | 70 | 2017 |
| Hyperglycemia and diabetes induced by glucocorticoids in nondiabetic and diabetic patients: revision of literature and personal considerations C Elena, M Chiara, B Angelica, MA Chiara, N Laura, C Chiara, C Claudio, ... Current pharmaceutical biotechnology 19 (15), 1210-1220, 2018 | 68 | 2018 |
| MicroRNAs: novel players in the dialogue between pancreatic islets and immune system in autoimmune diabetes G Ventriglia, L Nigi, G Sebastiani, F Dotta BioMed Research International 2015 (1), 749734, 2015 | 63 | 2015 |
| Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression G Sebastiani, G Ventriglia, A Stabilini, C Socci, C Morsiani, A Laurenzi, ... Scientific reports 7 (1), 6897, 2017 | 62 | 2017 |
| Serum levels of miR-148a and miR-21-5p are increased in type 1 diabetic patients and correlated with markers of bone strength and metabolism GE Grieco, D Cataldo, E Ceccarelli, L Nigi, G Catalano, N Brusco, ... Non-coding RNA 4 (4), 37, 2018 | 49 | 2018 |
| MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells G Sebastiani, M Valentini, GE Grieco, G Ventriglia, L Nigi, F Mancarella, ... Acta diabetologica 54, 265-281, 2017 | 43 | 2017 |
| Targeting microRNAs as a therapeutic strategy to reduce oxidative stress in diabetes GE Grieco, N Brusco, G Licata, L Nigi, C Formichi, F Dotta, G Sebastiani International journal of molecular sciences 20 (24), 6358, 2019 | 38 | 2019 |
| Acute on chronic limb ischemia: From surgical embolectomy and thrombolysis to endovascular options G de Donato, E Pasqui, F Setacci, G Palasciano, L Nigi, C Fondelli, ... Seminars in vascular surgery 31 (2-4), 66-75, 2018 | 37 | 2018 |
| The case for virus-induced type 1 diabetes I Spagnuolo, A Patti, G Sebastiani, L Nigi, F Dotta Current Opinion in Endocrinology, Diabetes and Obesity 20 (4), 292-298, 2013 | 29 | 2013 |
| MicroRNA profiling in sera of patients with type 2 diabetes mellitus reveals an upregulation of miR-31 expression in subjects with microvascular complications G Sebastiani, L Nigi, I Spagnuolo, E Morganti, C Fondelli, F Dotta Journal of Biomedical Science and Engineering 6, 58-64, 2013 | 29 | 2013 |
| Extracellular vesicles in immune system regulation and type 1 diabetes: cell-to-cell communication mediators, disease biomarkers, and promising therapeutic tools GE Grieco, D Fignani, C Formichi, L Nigi, G Licata, C Maccora, N Brusco, ... Frontiers in Immunology 12, 682948, 2021 | 27 | 2021 |
| Prospective validation of ATA and ETA sonographic pattern risk of thyroid nodules selected for FNAC F Maino, R Forleo, M Martinelli, N Fralassi, F Barbato, T Pilli, ... The Journal of Clinical Endocrinology & Metabolism 103 (6), 2362-2368, 2018 | 27 | 2018 |
